Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Global Oral GLP-1 Agonists Market 2026 2035 Report Code HF1128 Published June 4, 2026 Pages 220+ Format PDF, Excel Revenue, 2026 72.87 Billion Forecast, 2035 206.83 Billion CAGR, 2026-2035 12.25% Report Coverage Global Market Overview It is estimated that the global oral GLP-1 agonists market will be valued at approximately USD 65.15 billion in 2025, rising to around USD 72.87 billion in 2026, and is expected to reach close to USD 206.83 billion by 2035, expanding at a CAGR of 12.25% during the forecast period from 2026 to 2035
keep away from moisture and light Why Choose Reviv Peptides
Vukojevic J, Milavic M, Perovic D, et al
The Satiety and Clinical Adiposity Liraglutide Evidence (SCALE) Obesity and Prediabetes randomized, double-blind, placebo-controlled trial of 3.0 mg of once daily liraglutide achieved a mean 8.4 kg weight loss in patients with obesity without T2DM [7]
US$ 25.63
US$ 25.83
US$ 27.51
US$ 24.02
